Our preprint Early changes in lymphocyte/monocyte ratio on-treatment as a prognostic marker to predict overall survival in patients with advanced cancer treated with immune checkpoint inhibitors was posted today.
Read the preprint. This is a preprint and has not yet been peer reviewed.